STOCK TITAN

ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Starwood Property Trust (NYSE:STWD) announced a private offering of $500 million aggregate principal amount of unsecured senior notes due 2028. The company said it will allocate net proceeds to finance or refinance eligible green and social projects, and may apply proceeds to repay previously incurred indebtedness tied to those projects. Pending allocation, proceeds may be used for general corporate purposes, including repayment of outstanding indebtedness under the company's repurchase facilities. The Notes will be offered to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S, and will not be registered under the Securities Act.

Loading...
Loading translation...

Positive

  • $500 million debt raise announced
  • Proceeds earmarked for green and social projects
  • Proceeds can repay existing indebtedness

Negative

  • Notes are unsecured (no asset-backed claim)
  • Offering is private (Rule 144A/Reg S) and unregistered
  • Pending allocation, proceeds may be used for general corporate purposes

Insights

Starwood is issuing $500 million of unsecured notes due 2028, a meaningful debt raise to refinance or fund projects.

The company plans a private Rule 144A/Reg S offering of unsecured senior notes due 2028 with aggregate principal of $500 million. Proceeds will finance or refinance eligible green and social projects and may repay existing indebtedness pending allocation. The notes will not be registered and target qualified institutional buyers and non-U.S. persons.

Key dependencies include successful placement with institutional buyers and the timing of allocation to eligible projects, which affects permitted use of proceeds and potential balance-sheet effects. Watch near-term allocation disclosures and any use of proceeds for debt repayment; those items will surface within standard post-offering filings and within the offering closing timeline.

The offering links raising capital to green/social projects but temporarily allows general corporate uses until allocations complete.

Net proceeds are earmarked to finance or refinance eligible green and social projects, and previously incurred eligible costs may be paid down with proceeds. Until full allocation, the company may use proceeds for general corporate purposes, including repurchase facility debt repayment. The structuring as a private Rule 144A/Reg S placement limits the buyer base to institutional and non-U.S. investors.

Material items to monitor are the final allocation report and any statements about project eligibility and timing, which will clarify the environmental/social impact and compliance with any green financing assertions; expect those details in subsequent disclosures following the offering close.

UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting third quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on November 19, 2025, at 2:00 pm EST.

A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors and other individual followers to register and attend this live event.

Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s Investor website.

REGISTER HERE: https://www.renmarkfinancial.com/live-registration/third-quarter-2025-results-virtual-conference-call-nasdaq-prph-xgoCHA0tHl

  • To ensure smooth connectivity, please access this link using the latest version of Google Chrome.

About ProPhase Labs Inc.

ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development, such as our potentially life-saving test for the early detection of esophageal cancer, and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value. www.ProPhaseLabs.com

Media Relations Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com

Investor Relations Contact:
Dave Gentry, CEO
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
PRPH@redchip.com

Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (212) 812-7680
www.renmarkfinancial.com


FAQ

What is Starwood Property Trust announcing with the $500 million note offering (STWD)?

Starwood is offering $500 million of unsecured senior notes due 2028 in a private offering to qualified institutional buyers and non-U.S. persons.

How will Starwood (STWD) use the net proceeds from the $500M 2028 notes?

The company intends to allocate net proceeds to finance or refinance eligible green and social projects; pending allocation, proceeds may be used for general corporate purposes including debt repayment.

Who can buy the STWD 2028 notes and are they registered?

The Notes will be offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S; they will not be registered under the Securities Act.

What does it mean that the STWD notes are unsecured?

Unsecured notes are not backed by specific assets, so holders do not have a secured claim on property if the company defaults.

Could proceeds from the STWD offering reduce outstanding repurchase facility debt?

Yes, the company said proceeds may be used to repay outstanding indebtedness under its repurchase facilities.
Prophase Labs Inc

NASDAQ:PRPH

PRPH Rankings

PRPH Latest News

PRPH Latest SEC Filings

PRPH Stock Data

1.52M
5.44M
7.99%
6.57%
2.29%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States
NEW YORK